PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34149894-5	2021	Pathological changes and positive expression of VEGF in the ankle joints were investigated using hematoxylin-eosin staining and immunohistochemical staining, respectively.	Hematoxylin	97-108	vascular endothelial growth factor A	Rattus norvegicus	48-52	
31799638-9	2019	The expression level of VEGF in bone tissues at fracture ends of rats in the experimental group A, experimental group B and control group was observed through the hematoxylin-eosin (HE) staining.	Hematoxylin	163-174	vascular endothelial growth factor A	Rattus norvegicus	24-28	
23426508-5	2013	Hematoxylin-eosin staining revealed a marked increase in uterine eosinophilic infiltrations in ovariectomized rats treated with E2, E2+P4 or P4, which was associated with increased expression of vascular endothelial growth factor (VEGF), nuclear factor-kappaB (NF-kappaB), and tumor necrosis factor-alpha (TNF-alpha) proteins as determined by immunohistochemical and Western blot analysis.	Hematoxylin	0-11	vascular endothelial growth factor A	Rattus norvegicus	195-229	
23426508-5	2013	Hematoxylin-eosin staining revealed a marked increase in uterine eosinophilic infiltrations in ovariectomized rats treated with E2, E2+P4 or P4, which was associated with increased expression of vascular endothelial growth factor (VEGF), nuclear factor-kappaB (NF-kappaB), and tumor necrosis factor-alpha (TNF-alpha) proteins as determined by immunohistochemical and Western blot analysis.	Hematoxylin	0-11	vascular endothelial growth factor A	Rattus norvegicus	231-235